nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Sorafenib—liver cancer	0.224	0.622	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—liver cancer	0.136	0.378	CbGbCtD
Clofarabine—S-Adenosylmethionine—GNMT—liver cancer	0.0102	0.893	CrCbGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—liver cancer	0.00475	0.519	CbGdCrCtD
Clofarabine—DCK—Epirubicin—Doxorubicin—liver cancer	0.00439	0.481	CbGdCrCtD
Clofarabine—Liver injury—Epirubicin—liver cancer	0.00147	0.00353	CcSEcCtD
Clofarabine—Malnutrition—Sorafenib—liver cancer	0.00146	0.00351	CcSEcCtD
Clofarabine—Erythema—Sorafenib—liver cancer	0.00146	0.00351	CcSEcCtD
Clofarabine—Necrosis—Doxorubicin—liver cancer	0.00145	0.0035	CcSEcCtD
Clofarabine—Feeling hot—Doxorubicin—liver cancer	0.00145	0.0035	CcSEcCtD
Clofarabine—Petechiae—Doxorubicin—liver cancer	0.00139	0.00334	CcSEcCtD
Clofarabine—Viral infection—Epirubicin—liver cancer	0.00136	0.00329	CcSEcCtD
Clofarabine—Bone disorder—Epirubicin—liver cancer	0.00136	0.00329	CcSEcCtD
Clofarabine—Cellulitis—Epirubicin—liver cancer	0.00136	0.00326	CcSEcCtD
Clofarabine—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00136	0.00326	CcSEcCtD
Clofarabine—Liver injury—Doxorubicin—liver cancer	0.00136	0.00326	CcSEcCtD
Clofarabine—Anaemia—Sorafenib—liver cancer	0.00135	0.00324	CcSEcCtD
Clofarabine—Herpes simplex—Epirubicin—liver cancer	0.00134	0.00322	CcSEcCtD
Clofarabine—Hyperuricaemia—Epirubicin—liver cancer	0.00133	0.0032	CcSEcCtD
Clofarabine—Leukopenia—Sorafenib—liver cancer	0.00131	0.00314	CcSEcCtD
Clofarabine—Blood bilirubin increased—Epirubicin—liver cancer	0.0013	0.00314	CcSEcCtD
Clofarabine—Creatinine increased—Epirubicin—liver cancer	0.0013	0.00312	CcSEcCtD
Clofarabine—Bone pain—Epirubicin—liver cancer	0.00129	0.0031	CcSEcCtD
Clofarabine—Cough—Sorafenib—liver cancer	0.00127	0.00306	CcSEcCtD
Clofarabine—Viral infection—Doxorubicin—liver cancer	0.00126	0.00304	CcSEcCtD
Clofarabine—Bone disorder—Doxorubicin—liver cancer	0.00126	0.00304	CcSEcCtD
Clofarabine—Hypertension—Sorafenib—liver cancer	0.00126	0.00303	CcSEcCtD
Clofarabine—Blood uric acid increased—Epirubicin—liver cancer	0.00126	0.00302	CcSEcCtD
Clofarabine—Cellulitis—Doxorubicin—liver cancer	0.00125	0.00302	CcSEcCtD
Clofarabine—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00125	0.00302	CcSEcCtD
Clofarabine—Arthralgia—Sorafenib—liver cancer	0.00124	0.00299	CcSEcCtD
Clofarabine—Myalgia—Sorafenib—liver cancer	0.00124	0.00299	CcSEcCtD
Clofarabine—Herpes simplex—Doxorubicin—liver cancer	0.00124	0.00298	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00123	0.00297	CcSEcCtD
Clofarabine—Hepatocellular injury—Epirubicin—liver cancer	0.00123	0.00297	CcSEcCtD
Clofarabine—Hyperuricaemia—Doxorubicin—liver cancer	0.00123	0.00296	CcSEcCtD
Clofarabine—S-Adenosylmethionine—CYP2E1—liver cancer	0.00122	0.107	CrCbGaD
Clofarabine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00121	0.0029	CcSEcCtD
Clofarabine—Creatinine increased—Doxorubicin—liver cancer	0.0012	0.00289	CcSEcCtD
Clofarabine—Bone pain—Doxorubicin—liver cancer	0.00119	0.00287	CcSEcCtD
Clofarabine—Colitis—Epirubicin—liver cancer	0.00118	0.00285	CcSEcCtD
Clofarabine—Infection—Sorafenib—liver cancer	0.00118	0.00285	CcSEcCtD
Clofarabine—Skin exfoliation—Epirubicin—liver cancer	0.00118	0.00283	CcSEcCtD
Clofarabine—Candida infection—Epirubicin—liver cancer	0.00118	0.00283	CcSEcCtD
Clofarabine—Nervous system disorder—Sorafenib—liver cancer	0.00117	0.00281	CcSEcCtD
Clofarabine—Thrombocytopenia—Sorafenib—liver cancer	0.00117	0.00281	CcSEcCtD
Clofarabine—Blood uric acid increased—Doxorubicin—liver cancer	0.00116	0.0028	CcSEcCtD
Clofarabine—Skin disorder—Sorafenib—liver cancer	0.00116	0.00278	CcSEcCtD
Clofarabine—Hepatocellular injury—Doxorubicin—liver cancer	0.00114	0.00275	CcSEcCtD
Clofarabine—Anorexia—Sorafenib—liver cancer	0.00113	0.00273	CcSEcCtD
Clofarabine—Rash maculo-papular—Epirubicin—liver cancer	0.00112	0.0027	CcSEcCtD
Clofarabine—Neoplasm—Epirubicin—liver cancer	0.00111	0.00268	CcSEcCtD
Clofarabine—Mouth ulceration—Epirubicin—liver cancer	0.00111	0.00268	CcSEcCtD
Clofarabine—Pulmonary oedema—Epirubicin—liver cancer	0.0011	0.00264	CcSEcCtD
Clofarabine—Colitis—Doxorubicin—liver cancer	0.0011	0.00264	CcSEcCtD
Clofarabine—Skin exfoliation—Doxorubicin—liver cancer	0.00109	0.00262	CcSEcCtD
Clofarabine—Candida infection—Doxorubicin—liver cancer	0.00109	0.00262	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00108	0.00261	CcSEcCtD
Clofarabine—Sepsis—Epirubicin—liver cancer	0.00107	0.00258	CcSEcCtD
Clofarabine—Dyspnoea—Sorafenib—liver cancer	0.00106	0.00255	CcSEcCtD
Clofarabine—Rash maculo-papular—Doxorubicin—liver cancer	0.00104	0.0025	CcSEcCtD
Clofarabine—Decreased appetite—Sorafenib—liver cancer	0.00103	0.00249	CcSEcCtD
Clofarabine—Mouth ulceration—Doxorubicin—liver cancer	0.00103	0.00248	CcSEcCtD
Clofarabine—Neoplasm—Doxorubicin—liver cancer	0.00103	0.00248	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00103	0.00247	CcSEcCtD
Clofarabine—Fatigue—Sorafenib—liver cancer	0.00103	0.00247	CcSEcCtD
Clofarabine—Pain—Sorafenib—liver cancer	0.00102	0.00245	CcSEcCtD
Clofarabine—Pulmonary oedema—Doxorubicin—liver cancer	0.00102	0.00244	CcSEcCtD
Clofarabine—Sepsis—Doxorubicin—liver cancer	0.00099	0.00238	CcSEcCtD
Clofarabine—Gastrointestinal pain—Sorafenib—liver cancer	0.000973	0.00234	CcSEcCtD
Clofarabine—Renal failure acute—Epirubicin—liver cancer	0.000969	0.00233	CcSEcCtD
Clofarabine—Body temperature increased—Sorafenib—liver cancer	0.000941	0.00227	CcSEcCtD
Clofarabine—Abdominal pain—Sorafenib—liver cancer	0.000941	0.00227	CcSEcCtD
Clofarabine—Lethargy—Epirubicin—liver cancer	0.000913	0.0022	CcSEcCtD
Clofarabine—Renal failure acute—Doxorubicin—liver cancer	0.000897	0.00216	CcSEcCtD
Clofarabine—Pain in extremity—Epirubicin—liver cancer	0.000895	0.00215	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000895	0.00215	CcSEcCtD
Clofarabine—Hypersensitivity—Sorafenib—liver cancer	0.000877	0.00211	CcSEcCtD
Clofarabine—Asthenia—Sorafenib—liver cancer	0.000854	0.00206	CcSEcCtD
Clofarabine—Lethargy—Doxorubicin—liver cancer	0.000845	0.00203	CcSEcCtD
Clofarabine—Pruritus—Sorafenib—liver cancer	0.000842	0.00203	CcSEcCtD
Clofarabine—Blood creatinine increased—Epirubicin—liver cancer	0.000838	0.00202	CcSEcCtD
Clofarabine—Dehydration—Epirubicin—liver cancer	0.000832	0.002	CcSEcCtD
Clofarabine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000828	0.00199	CcSEcCtD
Clofarabine—Pain in extremity—Doxorubicin—liver cancer	0.000828	0.00199	CcSEcCtD
Clofarabine—Dry skin—Epirubicin—liver cancer	0.00082	0.00197	CcSEcCtD
Clofarabine—Abdominal pain upper—Epirubicin—liver cancer	0.000817	0.00197	CcSEcCtD
Clofarabine—Diarrhoea—Sorafenib—liver cancer	0.000814	0.00196	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000806	0.00194	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000806	0.00194	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000789	0.0019	CcSEcCtD
Clofarabine—Dizziness—Sorafenib—liver cancer	0.000787	0.00189	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—liver cancer	0.000776	0.00187	CcSEcCtD
Clofarabine—Influenza—Epirubicin—liver cancer	0.000773	0.00186	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—liver cancer	0.00077	0.00185	CcSEcCtD
Clofarabine—Dry skin—Doxorubicin—liver cancer	0.000759	0.00183	CcSEcCtD
Clofarabine—Pancreatitis—Epirubicin—liver cancer	0.000758	0.00183	CcSEcCtD
Clofarabine—Vomiting—Sorafenib—liver cancer	0.000757	0.00182	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—liver cancer	0.000756	0.00182	CcSEcCtD
Clofarabine—Rash—Sorafenib—liver cancer	0.00075	0.00181	CcSEcCtD
Clofarabine—Dermatitis—Sorafenib—liver cancer	0.00075	0.0018	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000746	0.0018	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000746	0.0018	CcSEcCtD
Clofarabine—Headache—Sorafenib—liver cancer	0.000746	0.0018	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—liver cancer	0.000735	0.00177	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00073	0.00176	CcSEcCtD
Clofarabine—Neutropenia—Epirubicin—liver cancer	0.000723	0.00174	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000719	0.00173	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—liver cancer	0.000716	0.00172	CcSEcCtD
Clofarabine—Nausea—Sorafenib—liver cancer	0.000707	0.0017	CcSEcCtD
Clofarabine—Pancreatitis—Doxorubicin—liver cancer	0.000702	0.00169	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—liver cancer	0.0007	0.00168	CcSEcCtD
Clofarabine—Pneumonia—Epirubicin—liver cancer	0.000694	0.00167	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—liver cancer	0.00069	0.00166	CcSEcCtD
Clofarabine—Infestation—Epirubicin—liver cancer	0.00069	0.00166	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000684	0.00165	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—liver cancer	0.00068	0.00164	CcSEcCtD
Clofarabine—Renal failure—Epirubicin—liver cancer	0.000678	0.00163	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—liver cancer	0.000676	0.00163	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—liver cancer	0.000672	0.00162	CcSEcCtD
Clofarabine—Jaundice—Epirubicin—liver cancer	0.000672	0.00162	CcSEcCtD
Clofarabine—Neutropenia—Doxorubicin—liver cancer	0.000669	0.00161	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000665	0.0016	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—liver cancer	0.000658	0.00158	CcSEcCtD
Clofarabine—Hepatobiliary disease—Epirubicin—liver cancer	0.000652	0.00157	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—liver cancer	0.00065	0.00157	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—liver cancer	0.000647	0.00156	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—liver cancer	0.000647	0.00156	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—liver cancer	0.000642	0.00155	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—liver cancer	0.000638	0.00154	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—liver cancer	0.000638	0.00154	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000633	0.00152	CcSEcCtD
Clofarabine—Renal failure—Doxorubicin—liver cancer	0.000627	0.00151	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000626	0.00151	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—liver cancer	0.000622	0.0015	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—liver cancer	0.000622	0.0015	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—liver cancer	0.000622	0.0015	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—liver cancer	0.000619	0.00149	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—liver cancer	0.000611	0.00147	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—liver cancer	0.00061	0.00147	CcSEcCtD
Clofarabine—Haematuria—Doxorubicin—liver cancer	0.000608	0.00146	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—liver cancer	0.000608	0.00146	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—liver cancer	0.000607	0.00146	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000604	0.00145	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—liver cancer	0.000602	0.00145	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—liver cancer	0.000599	0.00144	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—liver cancer	0.000585	0.00141	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—liver cancer	0.000576	0.00139	CcSEcCtD
Clofarabine—Flushing—Epirubicin—liver cancer	0.000575	0.00138	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—liver cancer	0.000575	0.00138	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—liver cancer	0.000573	0.00138	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—liver cancer	0.000566	0.00136	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—liver cancer	0.000564	0.00136	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—liver cancer	0.000563	0.00136	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—liver cancer	0.000562	0.00135	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—liver cancer	0.000562	0.00135	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—liver cancer	0.000559	0.00135	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—liver cancer	0.000558	0.00134	CcSEcCtD
Clofarabine—Chills—Epirubicin—liver cancer	0.000556	0.00134	CcSEcCtD
Clofarabine—Alopecia—Epirubicin—liver cancer	0.000547	0.00132	CcSEcCtD
Clofarabine—Mental disorder—Epirubicin—liver cancer	0.000542	0.00131	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—liver cancer	0.000542	0.0013	CcSEcCtD
Clofarabine—Erythema—Epirubicin—liver cancer	0.000539	0.0013	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—liver cancer	0.000539	0.0013	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—liver cancer	0.000532	0.00128	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—liver cancer	0.000532	0.00128	CcSEcCtD
Clofarabine—Back pain—Epirubicin—liver cancer	0.000521	0.00126	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—liver cancer	0.00052	0.00125	CcSEcCtD
Clofarabine—Immune system disorder—Doxorubicin—liver cancer	0.000517	0.00125	CcSEcCtD
Clofarabine—Mediastinal disorder—Doxorubicin—liver cancer	0.000516	0.00124	CcSEcCtD
Clofarabine—Chills—Doxorubicin—liver cancer	0.000514	0.00124	CcSEcCtD
Clofarabine—Alopecia—Doxorubicin—liver cancer	0.000506	0.00122	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—liver cancer	0.000502	0.00121	CcSEcCtD
Clofarabine—Erythema—Doxorubicin—liver cancer	0.000499	0.0012	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—liver cancer	0.000499	0.0012	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—liver cancer	0.000498	0.0012	CcSEcCtD
Clofarabine—Agitation—Epirubicin—liver cancer	0.000495	0.00119	CcSEcCtD
Clofarabine—DCK—Metabolism—EPT1—liver cancer	0.000491	0.00241	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—liver cancer	0.000488	0.00239	CbGpPWpGaD
Clofarabine—Leukopenia—Epirubicin—liver cancer	0.000482	0.00116	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—liver cancer	0.000482	0.00116	CcSEcCtD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—liver cancer	0.000479	0.00235	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—liver cancer	0.000474	0.00233	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN1A—liver cancer	0.000472	0.00231	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.00047	0.00231	CbGpPWpGaD
Clofarabine—Cough—Epirubicin—liver cancer	0.00047	0.00113	CcSEcCtD
Clofarabine—DCK—Metabolism—TAT—liver cancer	0.000466	0.00229	CbGpPWpGaD
Clofarabine—Hypertension—Epirubicin—liver cancer	0.000465	0.00112	CcSEcCtD
Clofarabine—RRM2—G1/S Transition—MYC—liver cancer	0.000464	0.00228	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PSMA4—liver cancer	0.000463	0.00227	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PSMD10—liver cancer	0.000463	0.00227	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000461	0.00226	CbGpPWpGaD
Clofarabine—Anaemia—Doxorubicin—liver cancer	0.000461	0.00111	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1B—liver cancer	0.000459	0.00225	CbGpPWpGaD
Clofarabine—Myalgia—Epirubicin—liver cancer	0.000459	0.0011	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—liver cancer	0.000459	0.0011	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—liver cancer	0.000459	0.00225	CbGpPWpGaD
Clofarabine—Agitation—Doxorubicin—liver cancer	0.000458	0.0011	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—liver cancer	0.000457	0.0011	CcSEcCtD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000457	0.00224	CbGpPWpGaD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000456	0.0011	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—PSMD10—liver cancer	0.000453	0.00222	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PSMA4—liver cancer	0.000453	0.00222	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000453	0.00222	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000449	0.0022	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000448	0.0022	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—liver cancer	0.000446	0.00107	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000444	0.00218	CbGpPWpGaD
Clofarabine—Oedema—Epirubicin—liver cancer	0.00044	0.00106	CcSEcCtD
Clofarabine—POLA1—E2F transcription factor network—MYC—liver cancer	0.000438	0.00215	CbGpPWpGaD
Clofarabine—Infection—Epirubicin—liver cancer	0.000437	0.00105	CcSEcCtD
Clofarabine—Cough—Doxorubicin—liver cancer	0.000435	0.00105	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000434	0.00213	CbGpPWpGaD
Clofarabine—Nervous system disorder—Epirubicin—liver cancer	0.000431	0.00104	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1B—liver cancer	0.000431	0.00211	CbGpPWpGaD
Clofarabine—Thrombocytopenia—Epirubicin—liver cancer	0.000431	0.00104	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—liver cancer	0.000431	0.00104	CcSEcCtD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.00043	0.00211	CbGpPWpGaD
Clofarabine—Tachycardia—Epirubicin—liver cancer	0.000429	0.00103	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—liver cancer	0.000427	0.00103	CcSEcCtD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000427	0.00209	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—liver cancer	0.000425	0.00102	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—liver cancer	0.000425	0.00102	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—liver cancer	0.000425	0.00102	CcSEcCtD
Clofarabine—POLA1—Synthesis of DNA—CDKN1A—liver cancer	0.000424	0.00208	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000424	0.00208	CbGpPWpGaD
Clofarabine—Anxiety—Doxorubicin—liver cancer	0.000423	0.00102	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000422	0.00102	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—liver cancer	0.000419	0.00101	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1B—liver cancer	0.000415	0.00204	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GLUL—liver cancer	0.000411	0.00202	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CPT1B—liver cancer	0.000411	0.00202	CbGpPWpGaD
Clofarabine—Hypotension—Epirubicin—liver cancer	0.000411	0.00099	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.00041	0.00201	CbGpPWpGaD
Clofarabine—Oedema—Doxorubicin—liver cancer	0.000407	0.00098	CcSEcCtD
Clofarabine—Infection—Doxorubicin—liver cancer	0.000404	0.000973	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000401	0.000965	CcSEcCtD
Clofarabine—Nervous system disorder—Doxorubicin—liver cancer	0.000399	0.000961	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—liver cancer	0.000398	0.000959	CcSEcCtD
Clofarabine—POLA1—DNA Replication—CDKN1A—liver cancer	0.000398	0.00195	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000397	0.00195	CbGpPWpGaD
Clofarabine—Tachycardia—Doxorubicin—liver cancer	0.000397	0.000956	CcSEcCtD
Clofarabine—RRM1—Metabolism—NR1H4—liver cancer	0.000397	0.00195	CbGpPWpGaD
Clofarabine—Skin disorder—Doxorubicin—liver cancer	0.000395	0.000952	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—liver cancer	0.000395	0.000951	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—liver cancer	0.000395	0.00194	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Doxorubicin—liver cancer	0.000393	0.000947	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—liver cancer	0.000392	0.000944	CcSEcCtD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—liver cancer	0.000391	0.00192	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000391	0.00192	CbGpPWpGaD
Clofarabine—Somnolence—Epirubicin—liver cancer	0.000391	0.000941	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTA3—liver cancer	0.00039	0.00191	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.00039	0.00191	CbGpPWpGaD
Clofarabine—Anorexia—Doxorubicin—liver cancer	0.000388	0.000934	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—CDKN1A—liver cancer	0.000383	0.00188	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—liver cancer	0.000382	0.000921	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—liver cancer	0.00038	0.000916	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—liver cancer	0.00038	0.00187	CbGpPWpGaD
Clofarabine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00038	0.000914	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—liver cancer	0.000379	0.000913	CcSEcCtD
Clofarabine—POLA1—S Phase—CDKN1B—liver cancer	0.000377	0.00185	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—liver cancer	0.000376	0.000906	CcSEcCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—liver cancer	0.000371	0.00182	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000371	0.000893	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000368	0.00181	CbGpPWpGaD
Clofarabine—Paraesthesia—Doxorubicin—liver cancer	0.000365	0.00088	CcSEcCtD
Clofarabine—Dyspnoea—Doxorubicin—liver cancer	0.000363	0.000874	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—liver cancer	0.000362	0.000873	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—liver cancer	0.000362	0.000871	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.00036	0.00177	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—liver cancer	0.00036	0.000866	CcSEcCtD
Clofarabine—POLA1—S Phase—CCND1—liver cancer	0.000359	0.00176	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000359	0.00176	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTA4—liver cancer	0.000357	0.00175	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—liver cancer	0.000354	0.000852	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000351	0.000846	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—liver cancer	0.000351	0.000845	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—liver cancer	0.00035	0.00172	CbGpPWpGaD
Clofarabine—Pain—Doxorubicin—liver cancer	0.000348	0.000838	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—liver cancer	0.000348	0.000837	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—liver cancer	0.000348	0.000837	CcSEcCtD
Clofarabine—RRM1—Metabolism—GSTA2—liver cancer	0.000348	0.00171	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CDKN1A—liver cancer	0.000348	0.00171	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000346	0.0017	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000346	0.0017	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000342	0.00168	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CPT1B—liver cancer	0.000339	0.00166	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GLUL—liver cancer	0.000339	0.00166	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTA1—liver cancer	0.000335	0.00165	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—liver cancer	0.000335	0.000807	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000335	0.00164	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—liver cancer	0.000334	0.00164	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000333	0.000801	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000333	0.00163	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—NAT2—liver cancer	0.000332	0.00163	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000329	0.00161	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NR1H4—liver cancer	0.000327	0.0016	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—liver cancer	0.000324	0.00078	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—liver cancer	0.000323	0.00158	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000323	0.00158	CbGpPWpGaD
Clofarabine—Abdominal pain—Doxorubicin—liver cancer	0.000322	0.000775	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—liver cancer	0.000322	0.000775	CcSEcCtD
Clofarabine—RRM2—Metabolism—GSTA3—liver cancer	0.000321	0.00158	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PCNA—liver cancer	0.00032	0.00157	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALDOB—liver cancer	0.000318	0.00156	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—MYC—liver cancer	0.000317	0.00156	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GLUL—liver cancer	0.000317	0.00155	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CPT1B—liver cancer	0.000317	0.00155	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—liver cancer	0.000316	0.00076	CcSEcCtD
Clofarabine—POLA1—Mitotic M-M/G1 phases—H2AFX—liver cancer	0.000313	0.00154	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—liver cancer	0.000312	0.00153	CbGpPWpGaD
Clofarabine—Pruritus—Epirubicin—liver cancer	0.000311	0.000749	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—PSMD10—liver cancer	0.00031	0.00152	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PSMA4—liver cancer	0.00031	0.00152	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—H2AFX—liver cancer	0.000306	0.0015	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000306	0.0015	CbGpPWpGaD
Clofarabine—DCK—Metabolism—NR1H4—liver cancer	0.000305	0.0015	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CRABP1—liver cancer	0.000303	0.00149	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000302	0.00148	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—liver cancer	0.000301	0.000725	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTA3—liver cancer	0.0003	0.00147	CbGpPWpGaD
Clofarabine—Hypersensitivity—Doxorubicin—liver cancer	0.0003	0.000722	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000296	0.00145	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTA4—liver cancer	0.000294	0.00144	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—liver cancer	0.000292	0.000703	CcSEcCtD
Clofarabine—Dizziness—Epirubicin—liver cancer	0.000291	0.0007	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000289	0.00142	CbGpPWpGaD
Clofarabine—POLA1—S Phase—MYC—liver cancer	0.000288	0.00141	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—liver cancer	0.000288	0.000693	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000288	0.00141	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PCNA—liver cancer	0.000287	0.00141	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTA2—liver cancer	0.000286	0.0014	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000282	0.00138	CbGpPWpGaD
Clofarabine—Vomiting—Epirubicin—liver cancer	0.00028	0.000673	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—liver cancer	0.000278	0.00067	CcSEcCtD
Clofarabine—Rash—Epirubicin—liver cancer	0.000277	0.000668	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—liver cancer	0.000277	0.000667	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TERT—liver cancer	0.000277	0.00136	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTA1—liver cancer	0.000276	0.00136	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000276	0.00135	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000276	0.00135	CbGpPWpGaD
Clofarabine—Headache—Epirubicin—liver cancer	0.000276	0.000663	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTA4—liver cancer	0.000275	0.00135	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—NAT2—liver cancer	0.000273	0.00134	CbGpPWpGaD
Clofarabine—Dizziness—Doxorubicin—liver cancer	0.000269	0.000648	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—liver cancer	0.000268	0.00131	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTA2—liver cancer	0.000268	0.00131	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HPGDS—liver cancer	0.000265	0.0013	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000265	0.0013	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALDOB—liver cancer	0.000262	0.00128	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—liver cancer	0.000261	0.000629	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000261	0.00128	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.00026	0.00127	CbGpPWpGaD
Clofarabine—Vomiting—Doxorubicin—liver cancer	0.000259	0.000623	CcSEcCtD
Clofarabine—DCK—Metabolism—GSTA1—liver cancer	0.000258	0.00127	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—liver cancer	0.000257	0.000618	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—liver cancer	0.000256	0.000617	CcSEcCtD
Clofarabine—DCK—Metabolism—NAT2—liver cancer	0.000255	0.00125	CbGpPWpGaD
Clofarabine—Headache—Doxorubicin—liver cancer	0.000255	0.000614	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000253	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000252	0.00124	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.00025	0.00123	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CRABP1—liver cancer	0.00025	0.00123	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00025	0.00122	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALDOB—liver cancer	0.000245	0.0012	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000244	0.0012	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—liver cancer	0.000242	0.000582	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000239	0.00117	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PSMA4—liver cancer	0.000236	0.00116	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PSMD10—liver cancer	0.000236	0.00116	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000234	0.00115	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CRABP1—liver cancer	0.000233	0.00115	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GOT2—liver cancer	0.00023	0.00113	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.00022	0.00108	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PCNA—liver cancer	0.000219	0.00108	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HPGDS—liver cancer	0.000218	0.00107	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP2E1—liver cancer	0.000216	0.00106	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000212	0.00104	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—H2AFX—liver cancer	0.000209	0.00103	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—UGDH—liver cancer	0.000209	0.00103	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HPGDS—liver cancer	0.000204	0.001	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000203	0.000995	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYCS—liver cancer	0.000202	0.000992	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000202	0.000992	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GOT1—liver cancer	0.000198	0.000974	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GGT1—liver cancer	0.000198	0.000974	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—EPT1—liver cancer	0.000197	0.000965	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PCNA—liver cancer	0.000196	0.000961	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PSMA4—liver cancer	0.000195	0.000955	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PSMD10—liver cancer	0.000195	0.000955	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GOT2—liver cancer	0.000189	0.000929	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN2A—liver cancer	0.000189	0.000929	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—liver cancer	0.000189	0.000929	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000189	0.000926	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000187	0.00092	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000187	0.000919	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TAT—liver cancer	0.000186	0.000915	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PSMA4—liver cancer	0.000182	0.000892	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PSMD10—liver cancer	0.000182	0.000892	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.00018	0.000882	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—liver cancer	0.000179	0.000878	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTP1—liver cancer	0.000178	0.000875	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP2E1—liver cancer	0.000178	0.000873	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GOT2—liver cancer	0.000177	0.000868	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—HMOX1—liver cancer	0.000176	0.000863	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000173	0.000849	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000172	0.000844	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1B—liver cancer	0.000168	0.000823	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYCS—liver cancer	0.000167	0.000817	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000166	0.000817	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP2E1—liver cancer	0.000166	0.000816	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—GSTM1—liver cancer	0.000164	0.000804	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GGT1—liver cancer	0.000163	0.000802	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GOT1—liver cancer	0.000163	0.000802	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CCND1—liver cancer	0.00016	0.000785	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYCS—liver cancer	0.000156	0.000764	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CYP1A1—liver cancer	0.000155	0.000762	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—CDKN1A—liver cancer	0.000155	0.000759	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GOT1—liver cancer	0.000153	0.000749	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GGT1—liver cancer	0.000153	0.000749	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTP1—liver cancer	0.000147	0.00072	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000145	0.00071	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—HMOX1—liver cancer	0.000145	0.00071	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—MTHFR—liver cancer	0.000145	0.00071	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—liver cancer	0.000143	0.000704	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARA—liver cancer	0.000142	0.000697	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000141	0.00069	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTP1—liver cancer	0.000137	0.000673	CbGpPWpGaD
Clofarabine—DCK—Metabolism—HMOX1—liver cancer	0.000135	0.000664	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GSTM1—liver cancer	0.000135	0.000662	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000133	0.000652	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN2A—liver cancer	0.000129	0.000635	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—MYC—liver cancer	0.000128	0.000629	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000128	0.000629	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—CYP1A1—liver cancer	0.000128	0.000627	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GLUL—liver cancer	0.000127	0.000622	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CPT1B—liver cancer	0.000127	0.000622	CbGpPWpGaD
Clofarabine—DCK—Metabolism—GSTM1—liver cancer	0.000126	0.000618	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—liver cancer	0.000122	0.0006	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NR1H4—liver cancer	0.000122	0.000599	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CG—liver cancer	0.000122	0.000597	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA3—liver cancer	0.00012	0.000589	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CYP1A1—liver cancer	0.000119	0.000586	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—MTHFR—liver cancer	0.000119	0.000585	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000118	0.000581	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PPARG—liver cancer	0.000117	0.000576	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARA—liver cancer	0.000117	0.000574	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000116	0.000567	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1B—liver cancer	0.000115	0.000563	CbGpPWpGaD
Clofarabine—DCK—Metabolism—MTHFR—liver cancer	0.000111	0.000547	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA4—liver cancer	0.00011	0.000539	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—liver cancer	0.000109	0.000537	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARA—liver cancer	0.000109	0.000536	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA2—liver cancer	0.000107	0.000525	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—liver cancer	0.000107	0.000525	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CDKN1A—liver cancer	0.000106	0.000519	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ALB—liver cancer	0.000106	0.000518	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—TP53—liver cancer	0.000105	0.000517	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTA1—liver cancer	0.000103	0.000507	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—NAT2—liver cancer	0.000102	0.000501	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—liver cancer	0.0001	0.000491	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—liver cancer	9.81e-05	0.000481	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALDOB—liver cancer	9.79e-05	0.00048	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—liver cancer	9.67e-05	0.000474	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—liver cancer	9.36e-05	0.000459	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CRABP1—liver cancer	9.34e-05	0.000458	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—PPARA—liver cancer	9.34e-05	0.000458	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—liver cancer	9.32e-05	0.000457	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—liver cancer	9.03e-05	0.000443	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—liver cancer	8.81e-05	0.000432	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—liver cancer	8.77e-05	0.00043	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—ALB—liver cancer	8.69e-05	0.000426	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—liver cancer	8.23e-05	0.000404	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HPGDS—liver cancer	8.17e-05	0.000401	CbGpPWpGaD
Clofarabine—DCK—Metabolism—ALB—liver cancer	8.12e-05	0.000399	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—liver cancer	7.67e-05	0.000377	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PSMA4—liver cancer	7.28e-05	0.000357	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PSMD10—liver cancer	7.28e-05	0.000357	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—liver cancer	7.21e-05	0.000354	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—liver cancer	7.17e-05	0.000352	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GOT2—liver cancer	7.08e-05	0.000347	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	6.94e-05	0.000341	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP2E1—liver cancer	6.66e-05	0.000327	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	6.28e-05	0.000308	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYCS—liver cancer	6.23e-05	0.000306	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GOT1—liver cancer	6.11e-05	0.0003	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GGT1—liver cancer	6.11e-05	0.0003	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—liver cancer	5.68e-05	0.000279	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTP1—liver cancer	5.49e-05	0.000269	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—HMOX1—liver cancer	5.41e-05	0.000266	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GSTM1—liver cancer	5.04e-05	0.000248	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CYP1A1—liver cancer	4.78e-05	0.000235	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—liver cancer	4.68e-05	0.00023	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—liver cancer	4.64e-05	0.000228	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—MTHFR—liver cancer	4.46e-05	0.000219	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARA—liver cancer	4.37e-05	0.000215	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—liver cancer	4.37e-05	0.000215	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—liver cancer	3.82e-05	0.000188	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—liver cancer	3.75e-05	0.000184	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—liver cancer	3.62e-05	0.000177	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—liver cancer	3.57e-05	0.000175	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—liver cancer	3.29e-05	0.000162	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ALB—liver cancer	3.25e-05	0.000159	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—liver cancer	2.87e-05	0.000141	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—liver cancer	1.75e-05	8.58e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—liver cancer	1.43e-05	7.01e-05	CbGpPWpGaD
